Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
Condition(s):Hepatocellular Carcinoma; Nonalcoholic SteatohepatitisLast Updated:March 21, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Hepatocellular Carcinoma; Nonalcoholic SteatohepatitisLast Updated:March 21, 2024Recruiting
Condition(s):Prostate Cancer; Radiation Toxicity; Urinary ComplicationLast Updated:February 28, 2024Recruiting
Condition(s):HypertensionLast Updated:December 9, 2022Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:February 13, 2024Recruiting
Condition(s):Pacemakers, Heart FailureLast Updated:November 2, 2022Not yet recruiting
Condition(s):Diabetic Kidney DiseaseLast Updated:January 2, 2024Not yet recruiting
Condition(s):Renal Insufficiency, Chronic; Diabetic Nephropathy Type 2Last Updated:October 28, 2022Recruiting
Condition(s):Resistant Arterial HypertensionLast Updated:June 12, 2023Recruiting
Condition(s):AML; Acute Myeloid LeukemiaLast Updated:September 28, 2023Recruiting
Condition(s):Coronary Artery DiseaseLast Updated:February 10, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.